Investigation of the antimycobacterial activity ofAfrican medicinal plants combined with chemometric analysis to identify potential leads
No Thumbnail Available
Date
2024
Journal Title
Journal ISSN
Volume Title
Publisher
nature
Abstract
The emergence of drug-resistant Mycobacterium tuberculosis strains is a threat to global health necessitating the discovery of novel chemotherapeutic agents. Natural products drug discovery, which previously led to the discovery of rifamycins, is a valuable approach in this endeavor. Against
this backdrop, we set out to investigate the in vitro antimycobacterial properties of medicinal plants from Ghana and South Africa, evaluating 36 extracts and their 252 corresponding solid phase extraction (SPE) generated fractions primarily against the non-pathogenic Mycobacterium smegmatis
and Mycobacterium aurum species. The most potent fraction was further evaluated in vitro against infectious M. tuberculosis strain. Crinum asiaticum (bulb) (Amaryllidaceae) emerged as the most potent plant species with specifc fractions showing exceptional, near equipotent activity against the non pathogenic Mycobacterium species (0.39 µg/ml ≤MIC≤ 25 µg/ml) with one fraction being moderately active (MIC= 32.6 µg/ml) against M. tuberculosis. Metabolomic analysis led to the identifcation of eight compounds predicted to be active against M. smegmatis and M. aurum. In conclusion, from
our comprehensive study, we generated data which provided an insight into the antimycobacterial properties of Ghanaian and South African plants. Future work will be focused on the isolation and evaluation of the compounds predicted to be active.
Description
This article is published by nature, 2024 and is also available at https://doi.org/10.1038/s41598-024-65369-7
Keywords
Citation
Scientifc Reports | (2024) 14:14660